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Edited by Judit Ova´diAbstract Aminoacylase III (AAIII) plays an important role in
deacetylation of acetylated amino acids and N-acetylated S-cys-
teine conjugates of halogenated alkenes and alkanes. AAIII, re-
cently cloned from mouse kidney and partially characterized, is a
mixture of tetramers and dimers. In the present work, AAIII di-
mers were puriﬁed and shown to be enzymatically active. Limited
trypsinolysis showed two domains of 9 and 25 kDa. The three-
dimensional structure of the dimer was studied by electron
microscopy of negative stained samples and by single-particle
reconstruction. A 16 A˚ resolution model of the AAIII dimer
was created. It has an unusual, cage-like, structure. A realistic
AAIII tetramer model was built from two dimers.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aminoacylases with a broad range of substrate speciﬁcity
have been proposed to play a key role in deacetylation of N-
acetylated amino acids and several mercapturic acids [1]. Ami-
noacylase I (AAI; EC 3.5.1.14; N-acylamino acid hydrolase)
catalyzes the deacetylation of neutral aliphatic N-acyl-a-amino
acids and also several S-alkyl-derivatives of N-acetyl-L-cys-
teine including N-acetyl-S-(1,1,2,2-tetraﬂuoroethyl)-L-cysteine,
N-acetyl-S-(2-chloro-1,1,2-triﬂuoroethyl)-L-cysteine, N-acetyl-
S-(2-bromo-1,1,2-triﬂuoroethyl)-L-cysteine [1–6]. AAI is a sol-
uble protein and a homodimer of a 43 kDa monomer [5,7,8].
AAI puriﬁed from rat kidney with a relative molecular mass of
125 kDa was suggested to possess a trimeric structure [6]. AAI
contains one Zn2+ per monomer, which is absolutely required
for mediating its activity [4,8]. Limited trypsinolysis of AAI
puriﬁed from porcine kidney revealed a larger (half of total)
N-terminal and a smaller (quarter of total) C-terminal do-
main [9].
Aminoacylase III (AAIII) mediates deacetylation of N-acet-
yl-L-aromatic amino acids and several mercapturic acids
[1,10,11]. Since more than 50% of cellular proteins are N-ter-*Corresponding author. Fax: + 1 310 825 6309.
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ylated amino acids is a physiologically important cellular
process [12,13]. In addition, AAIII deacetylates several mer-
capturic acids or S-substituted N-acetyl-L-cysteine conjugates
derived from metabolism of the common industrial contami-
nant trichloroethylene, including N-acetyl-1,2-dichlorovinyl-
L-cysteine, N-acetyl-S-(2,2-dichlorovinyl)-L-cysteine, and also
N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine [10,14]. The prod-
ucts of mercapturic acids deacetylation become available for
bioactivation by cysteine conjugate b-lyase, which forms toxic
intermediates [15,16].
AAIII is less characterized than AAI at the structural level.
Mouse AAIII and rat liver aminoacylase with similar substrate
speciﬁcity were shown to be homotetramers of a 35 kDa
monomer [11,17]. In contrast, the molecular mass of rat kidney
aminoacylase with substrate speciﬁcity similar to AAIII in
non-denaturing conditions was 55 kDa, suggesting that it
may be a dimer of a 35 kDa monomer [10]. We have recently
shown that mouse AAIII expressed in HEK293T cells is a mix-
ture of tetramers and dimers [14]. Since the AAIII dimer may
be an intermediate between the monomer and tetramer, and/or
the dimer and tetramer may both be active forms of the en-
zyme with diﬀerent catalytic characteristics, it is important to
characterize them biochemically and structurally. Image anal-
ysis of electron micrographs of negatively stained mouse
AAIII tetramer revealed 4-fold rotational symmetry and a cav-
ity in the center of the tetramer, which might be a substrate-
binding site [11]. In this paper we examined whether the AAIII
dimer is a catalytically active form of AAIII and studied the
domain structure of the AAIII monomer by limited trypsinol-
ysis. We also characterized the three-dimensional (3D) struc-
ture of AAIII dimer by transmission electron microscopy
and single particle reconstruction [18].2. Materials and methods
2.1. Biochemical characterization of mouse AAIII
Mouse AAIII was expressed in HEK293T cells as a N-terminally
His6-tagged fusion protein and puriﬁed essentially as described [11],
except that the protein was extracted from the cells 2 days after trans-
fection since the longer period of expression increased the dimer/tetra-
mer ratio.
AAIII activity was measured with 10 mM S-benzyl-N-acetyl-L-cys-
teine as substrate by quantifying the amount of a deacetylated product
formed in a ﬂuorescence assay [11,19]. A calibration curve was createdblished by Elsevier B.V. All rights reserved.
Fig. 1. Oligomeric structure of mouse AAIII shown by SDS–PAGE.
Panel A shows a band of 35 kDa, corresponding to AAIII monomer,
by staining with Coomassie blue (lane 1) or by Western blot analysis
with the speciﬁc antibody, MR-C1 (lane 2). Panel B shows bands of
70 (lane 1) and 140 kDa (lane 2), corresponding to dimer and
tetramer, obtained after chromatography of AAIII on Sephacryl S-200
and cross-linking of the fractions to preserve the oligomeric structure
during SDS–PAGE.
S. Ryazantsev et al. / FEBS Letters 581 (2007) 1898–1902 1899with L-methionine. Protein was measured using a NanoOrange Protein
Quantitation kit (Molecular Probes, Eugene, OR, USA); puriﬁed
recombinant mouse AAIII was used for calibration.
Non-denaturing PAGE, SDS–PAGE and Western blotting were
performed as described [11]. An AAIII C-terminus speciﬁc antibody,
MR-C1 [11] was used at a dilution 1:2000 and anti-His antibody
(penta-His, Qiagen, Valencia, CA, USA) was used at a dilution
1:5000. Secondary horseradish peroxidase-conjugated species-speciﬁc
antibodies (Jackson Immunoresearch, West Grove, PA, USA) were
used at a dilution 1:20000.
AAIII dimer and tetramer fractions eluted from the Sephacryl S-200
column were cross-linked using bis(sulfosuccinimidyl) suberate (BS3)
from Pierce (Rockford, IL, USA) according to the manufacturer’s pro-
tocol.
Samples of puriﬁed His6-tagged or untagged AAIII dimers (100 lg)
were incubated at 20 C with diﬀerent amounts of MS-grade trypsin
(Stratagene, La Jolla, CA, USA) in a total volume of 100 ll. The reac-
tion was stopped at diﬀerent times by mixing 5 ll aliquots with an
equal volume of ice-cold 2· Laemmli buﬀer and boiling for 2 min,
and then analyzed by SDS–PAGE and Western blotting.Fig. 2. Identiﬁcation of domains of mouse AAIII by limited proteolysis wi
PAGE (panels A–F). The time of proteolysis (min) is shown above each lane.
or anti-His) are indicated below each panel.2.2. Electron microscopy and 3D reconstruction
Freshly prepared AAIII dimer samples (10–100 lg/ml in 50 mM
NH4-acetate, pH 7.4) were used for electron microscopy. ‘‘Double-car-
bon’’ negative staining was used with 1% aqueous uranyl acetate and a
very thin (14 A˚) carbon ﬁlm [20] to insure random orientation of the
particles. The samples were analyzed using a JEM-1200EX transmis-
sion electron microscope (JEOL, Japan) at 100 kV. Images were
recorded at a magniﬁcation of 55830 with a BioScan 600 W digital
camera (Gatan, Pleasanton, CA, USA); pixel size was 4.3 A˚.
3D reconstruction was performed using EMAN (Electron
Micrograph ANalysis) 1.7 software [18]. Micrographs were selected
in ctfcon (EMAN) that were in-focus, were astigmatism-free and did
not need contrast transfer function (CTF) correction. In the next step,
2300 individual dimeric AAIII particles were selected manually using
boxer (EMAN) with a box size of 48 · 48 pixels. Three starting models
were compared in the EMAN 3D reconstruction [18]: Gaussian fea-
tureless ellipsoid with a 1:2 axes ratio, Gaussian perfect sphere, and
a model built from randomly oriented ﬁve 40 A˚ blobs as a starting
model to see whether EMAN has a bias towards the starting model.
The resulting three low-resolution preliminary AAIII models showed
reachable similarity. Therefore, Gaussian featureless ellipsoid was used
for the ﬁnal 3D reconstruction. To reduce the eﬀect of uneven stain dis-
tribution, the mask = 10 option was used. During the reﬁnement pro-
cess, the generated model and its projections were compared to the
individual particles in the corresponding class. Particles signiﬁcantly
diﬀerent from the model projections were excluded. Raw particles were
used to calculate the ﬁnal model. The resulting model was tested for
resolution using t-test (EMAN). A cut-oﬀ of 0.5 in the Fourier shell
correlation (FSC) was used to determine the model resolution
[21,22]. The model density cut-oﬀ was determined in the EMAN reﬁne
routine to enclose a volume corresponding to a molecular mass of
70 kDa, assuming a protein density of 1.35 g/cm3 [23]. 3D rendering
and manipulation of the model were performed using Chimera
software [24].3. Results
3.1. Separation of mouse AAIII dimers from tetramers
The His6-tag of puriﬁed mouse AAIII (see Section 2.1) was
removed with enterokinase (Novagen, La Jolla, CA, USA) asth trypsin. The products of trypsin digestion were analyzed by SDS–
The AAIII used (His6-tagged or un-tagged) and the antibody (MRC-1
1900 S. Ryazantsev et al. / FEBS Letters 581 (2007) 1898–1902described [11], after which AAIII dimers were separated from
tetramers by gel-ﬁltration through a 1 · 100 cm Sephacryl
S-200 column. After digestion with enterokinase, the AAIII
preparation showed a single protein band of 35 kDa in
SDS–PAGE (Fig. 1A, lane 1); a single band of similar size
was detected on immunoblots of the gel (Fig. 1A, lane 2) with
MR-C1 antibody [11]. Two protein peaks of 140 and
70 kDa were detected after separation on the Sephacryl
S-200 column. SDS–PAGE of the cross-linked proteins in
these peaks (Fig. 1B) indicated that the 70 kDa fraction con-
tained predominantly the dimer (lane 1) and the 140 kDa
fraction predominantly the tetramer (lane 2). This was con-
ﬁrmed by electron microscopy (data not shown).
3.2. Catalytic activity of mouse AAIII dimers and tetramers
We determined that AAIII dimer as well as tetramer pos-
sessed enzymatic activity toward S-benzyl-N-acetyl-L-cysteine.
The speciﬁc activities of the dimer and tetramer wereFig. 3. Illustration of the AAIII dimer 3D reconstruction process. Panel A
and negatively stained with 1% aqueous uranyl acetate. Computer-generated F
shows comparison of model projections (left in each pair) and ﬁltered parti
particle orientations are shown. Panel C shows Euler space ﬁlling for the mo
correlation function) plot indicating 16 A˚ resolution at 0.5 FSC for the mod9.4 ± 1.6 lmol mg1 min1 and 11.7 ± 1.4 lmol mg1 min1,
respectively.
3.3. Limited digest of mouse AAIII dimer with trypsin
Limited trypsinolysis was used to probe the domain struc-
ture of mouse AAIII (Fig. 2A–F). When the His6-tagged di-
mers were used for trypsinolysis, 13 and 25 kDa fragments
were detected (Fig. 2A). When un-tagged dimers were used,
9 and 25 kDa fragments were obtained (Fig 2B). This result
indicates that the smaller fragment was fused to the 3 kDa
His6-tag peptide. Indeed, MRC-1 antibody, speciﬁc to the
C-terminus of AAIII reacted with the larger fragment tagged
(Fig. 2C) or un-tagged AAIII (Fig. 2D). The anti-His antibody
stained 13 kDa fragment in the digest of the tagged AAIII
(Fig. 2E). Predictably, no anti-His staining was observed in
the un-tagged sample (Fig 2F). This indicates that the
9 kDa fragment is N-terminal and the 25 kDa fragment is
C-terminal.represents electron micrograph of the AAIII sample, ‘‘double carbon’’
FT (fast Fourier transform) of the image is shown in an insert. Panel B
cle images from the corresponding class (right in each pair). Diﬀerent
del in EMAN coordinates [21]. Panel D represents FSC (Fourier shell
el.
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dimers
Fig. 3A shows a micrograph of a ﬁeld of negatively stained
AAIII dimer particles (Fig. 3A) that is virtually free of astig-
matism and drift as well as in focus (Fig. 3A, insert). Micro-
graphs of this quality were used for 3D reconstruction.
Because of high biochemical purity of the sample, we assumed
that most of the particles represented various views of AAIII
dimer. The oval, the largest projection, was considered to be
a front view, the small and round represented a top view,
and ‘‘triangle’’-like was a side view. The size of the particles
in the front view was approximately 70 · 120 A˚, with a notice-Fig. 4. 3D models of the dimer and tetramer of AAIII. Panels A–C
show arbitrary stereo views of the model rotated counter clockwise
around its vertical axis. Panel A is considered to be a front view and
Panel C is a back view. Panel D shows a proposed model of the
tetramer built from the two dimers (marked in yellow and blue) and
corresponding 2D electron density map (on the right). Two dimers are
attached back-to-back to each other; the dimer long axes are
perpendicular. The resolution was reduced to 20 A˚.able electron density area (35 · 35 A˚) in the center. Presence
of the particles in diﬀerent orientations indicated that there
was no predominant orientation of AAIII dimers on the
support ﬁlm.
Fig. 3B shows good agreement between 2D projections of
the model (left of each pair) with ﬁltered images (right of each
pair) of particles from the corresponding class. The classes rep-
resent diﬀerent orientations (front, top and side) of the parti-
cles. Fig. 3C shows that particles ﬁlled up most of the
classes, representing a wide spectrum of viewing directions
illustrated by the Euler’s space ﬁlling in EMAN coordinates.
It indicates that there is no preferential orientation of the par-
ticles on the support ﬁlm. On the basis of two independent
symmetry tests [18,25] (data not shown) the ﬁnal 3D model
was generated with C2 symmetry implemented. The model res-
olution at 0.5 FSC was 16 A˚ (see Fig. 3D).
The stereo model of the AAIII dimer is shown in Fig. 4A–C.
The protein is located at the periphery of the dimer, creating a
cavity in the center. The cavity is open from one side and sur-
rounded by protein protuberances, creating a unique ‘‘cage-
like’’ structure. Although overlapping protuberances on 2D
projections and particle orientation may make it diﬃcult to
recognize the cavity on some raw images, the cavity may be ob-
served as a darker area in the center of the particles (Fig. 3B).
Because both AAIII dimer and tetramer possess enzymatic
activity, it is possible that two functional dimers may associate
into a functional tetramer. The structure of the tetramer was
described previously [11]. It has a square shape with four dis-
tinct areas of protein density at the corners and a cavity in the
center. We performed modeling experiments to explore
whether two dimers could be arranged into a plausible 3D
model of the tetramer. 2D projection maps for diﬀerent dimer
orientations in the tetramer were generated in Chimera. An
orientation (Fig. 4D) was found in which the ﬂat sides of
two dimers (as in Fig. 4C) were in back-to-back contact and
their long axes were perpendicular (possible D2 symmetry).
The 2D projection map of the tetramer in such orientation is
shown in Fig. 4D, right. This projection is in good agreement
with the AAIII tetramer described in [11].4. Discussion
This work shows for the ﬁrst time that the AAIII dimer is a
functionally active form of the enzyme. The speciﬁc activity of
the dimer is not signiﬁcantly diﬀerent from that of the tetra-
mer. Tetrameric mouse AAIII and rat liver aminoacylase with
similar substrate speciﬁcity were shown to be functionally ac-
tive [11,17]. A 55 kDa (potentially dimeric) rat kidney amino-
acylase with substrate speciﬁcity similar to AAIII was also
functionally active [10]. It is quite possible that all these en-
zymes may exist in dimeric and tetrameric forms and that all
these forms are catalytically active. It is not clear whether di-
meric and tetrameric AAIII possess diﬀerent substrate speciﬁc-
ity and/or metabolite regulation.
The presence of two stable fragments after limited trypsinol-
ysis of AAIII demonstrated a possible two-domain structure of
the monomer. The smaller domain was at the N-terminus and
the larger one was at the C-terminus. A two-domain structure
was also shown for porcine AAI, but contrary to mouse
AAIII, the N-terminal domain was twice as large as the C-ter-
1902 S. Ryazantsev et al. / FEBS Letters 581 (2007) 1898–1902minal one [9]. In the model of the dimer, the asymmetric part,
or monomer, may be subdivided virtually into two unequal
parts that may correspond to the trypsin-resistant AAIII frag-
ments. It creates an opportunity to identify the AAIII domains
on a higher resolution 3D model. Obtaining the model with
better resolution will be the next step in our studies. Extensive
analysis of raw particles veriﬁed that the central cavity was a
characteristic feature of the AAIII dimer structure. We specu-
late that the active site of the AAIII dimer may be located in
the central cavity, similar to what was proposed for the tetra-
mer [11]. AAIII utilizes bulky substrates [1,10,11,14], and the
cavity may allow the substrates to bind to the active center.
Keeping in mind that AAIII dimer is catalytically active, it
may be suggested that AAIII tetramer has two active centers
separated from each other (see Fig. 4D).
These results show that a reasonable model may be created for
such small protein as AAIII using negative staining in combina-
tion with ‘‘double-carbon’’ technique and very thin carbon ﬁlm
[20]. Good biochemical sample quality, adequate preparation
technique and image quality are the main factors that lead to
the model with decent 16 A˚ resolution presented in this article.
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